When should insulin be initiated in diabetes (type 1 and type 2), including symptomatic hyperglycemia, plasma glucose ≥250 mg/dL, HbA1c ≥10%, pregnancy or uncontrolled gestational diabetes, eGFR <30 mL/min/1.73 m², acute catabolic states, and in older adults with limited life expectancy or hypoglycemia risk?

When to Initiate Insulin in Diabetes

Insulin should be started immediately in type 1 diabetes at diagnosis, and in type 2 diabetes when HbA1c ≥10%, fasting glucose ≥300 mg/dL with symptoms, or when ketosis/ketoacidosis is present. 1

---

Type 1 Diabetes: Immediate Insulin at Diagnosis

All patients with type 1 diabetes require insulin from the moment of diagnosis—there is no role for oral agents or delay. 2

Initial Regimen Structure

• Start with multiple daily injections (basal-bolus) using rapid-acting insulin 0–15 minutes before meals plus one or more daily injections of intermediate or long-acting basal insulin. 2
• Total daily dose: 0.4–1.0 units/kg/day, with 0.5 units/kg/day typical for metabolically stable patients; higher doses (up to 1.5 units/kg/day) are needed during puberty, pregnancy, or acute illness. 3
• Split the dose 40–50% basal and 50–60% prandial across three meals. 3

Glycemic Targets

• HbA1c target <7.5% (58 mmol/mol) for all children with type 1 diabetes, including preschool children, to minimize hyperglycemia, severe hypoglycemia, and long-term complications. 2
• Fasting glucose 80–130 mg/dL for adults. 1

Critical Pitfall

• Never use sliding-scale insulin as monotherapy in type 1 diabetes—it can precipitate diabetic ketoacidosis. 3

---

Type 2 Diabetes: Specific Indications for Insulin

Immediate Insulin Required (Start Without Delay)

1. Severe Hyperglycemia with Metabolic Decompensation

• Ketosis or diabetic ketoacidosis: Start IV or subcutaneous insulin immediately to correct hyperglycemia and metabolic derangement; once acidosis resolves, continue subcutaneous insulin and add metformin. 1, 4
• Blood glucose ≥600 mg/dL: Assess for hyperglycemic hyperosmolar syndrome and initiate insulin urgently. 1, 4

2. Marked Symptomatic Hyperglycemia

• Blood glucose ≥250 mg/dL (13.9 mmol/L) AND HbA1c ≥8.5% (69 mmol/mol) with polyuria, polydipsia, nocturia, or weight loss: Start basal insulin while initiating and titrating metformin. 1
• This applies to both adults and youth with type 2 diabetes. 1

3. Very High HbA1c at Diagnosis

• HbA1c ≥10% (86 mmol/mol): Insulin is essential when diet, physical activity, and other agents have been optimally used; oral agents alone reduce HbA1c by only 0.9–1.1%, which is insufficient. 1, 5, 2
• Start dual therapy with metformin plus basal insulin immediately rather than waiting 3 months for oral monotherapy to fail. 5

4. Pregnancy or Gestational Diabetes

• Insulin is the treatment of choice when oral agents fail to achieve glycemic targets in pregnancy or when gestational diabetes is uncontrolled. 1, 6

5. Advanced Chronic Kidney Disease

• eGFR <30 mL/min/1.73 m²: Insulin becomes necessary as most oral agents are contraindicated or require dose reduction; metformin is contraindicated below this threshold. 6

6. Acute Catabolic States

• During acute illness, surgery, infection, or hospitalization with severe hyperglycemia, insulin is required to rapidly control glucose and prevent metabolic decompensation. 1, 2, 7

---

Type 2 Diabetes: Elective Insulin Initiation

When Oral Agents and GLP-1 RA Fail

Start basal insulin when HbA1c remains ≥7.5% (58 mmol/mol) after 3–6 months of optimized oral therapy (metformin plus at least one additional agent). 1, 2

Initial Basal Insulin Dosing

• 10 units once daily at bedtime OR 0.1–0.2 units/kg body weight for insulin-naïve patients. 1, 3, 8
• For severe hyperglycemia (HbA1c ≥9%), consider higher starting doses of 0.3–0.5 units/kg/day split 50% basal and 50% prandial. 3

Titration Protocol

• Increase by 2 units every 3 days if fasting glucose 140–179 mg/dL. 1, 3
• Increase by 4 units every 3 days if fasting glucose ≥180 mg/dL. 1, 3
• Target fasting glucose 80–130 mg/dL (4.4–7.2 mmol/L). 1, 8
• If hypoglycemia occurs, reduce dose by 10–20% immediately. 1, 3

Critical Threshold: When to Add Prandial Insulin

• When basal insulin approaches 0.5–1.0 units/kg/day without achieving HbA1c <7%, add prandial insulin rather than continuing basal escalation to avoid "over-basalization." 3
• Signs of over-basalization: basal dose >0.5 units/kg/day, bedtime-to-morning glucose differential ≥50 mg/dL, hypoglycemia episodes, high glucose variability. 3

Prandial Insulin Initiation

• Start with 4 units rapid-acting insulin before the largest meal OR 10% of current basal dose. 3
• Administer 0–15 minutes before meals. 3, 2
• Titrate by 1–2 units every 3 days based on 2-hour postprandial glucose, targeting <180 mg/dL. 3

---

Special Populations

Older Adults with Limited Life Expectancy

• Target HbA1c 7.5–8.0% rather than <7% in patients with limited life expectancy (<10 years), extensive comorbidities, or history of severe hypoglycemia. 5, 4
• Lower insulin doses (0.1–0.25 units/kg/day) are appropriate for elderly patients (>65 years), those with renal impairment, or poor oral intake to minimize hypoglycemia risk. 3

Hospitalized Patients

• Non-critically ill: Start basal-bolus regimen with total daily dose 0.3–0.5 units/kg/day (50% basal, 50% prandial divided among three meals). 3
• High-risk patients (age >65, renal impairment, poor intake): Use lower starting dose of 0.1–0.25 units/kg/day. 3
• Patients on high-dose home insulin (≥0.6 units/kg/day): Reduce total daily dose by 20% on admission to prevent hypoglycemia. 3

---

Essential Principles for Insulin Therapy

Continue Metformin

• Never discontinue metformin when adding insulin unless contraindicated (eGFR <30 mL/min/1.73 m²); metformin reduces insulin requirements by 20–30%, mitigates weight gain, and provides cardiovascular benefit. 3, 5, 2

Monitoring Requirements

• Daily fasting glucose during titration to guide basal adjustments. 1, 3
• Pre-meal glucose before each meal to calculate correction doses. 3
• 2-hour postprandial glucose after meals to assess prandial adequacy. 3
• HbA1c every 3 months during intensive titration. 3, 5

Avoid Therapeutic Inertia

• Intensify therapy within 3 months if HbA1c remains above target; delays prolong hyperglycemia exposure and increase complication risk. 5

Patient Education Essentials

• Proper injection technique and site rotation to prevent lipohypertrophy. 3, 2
• Recognition and treatment of hypoglycemia (15 g fast-acting carbohydrate for glucose <70 mg/dL). 3
• Sick-day management: continue insulin even if not eating, check glucose every 4 hours. 3

---

Common Pitfalls to Avoid

• Do not delay insulin initiation when HbA1c ≥10% or glucose ≥300 mg/dL with symptoms—prolonged hyperglycemia increases complication risk. 5, 6
• Do not use sliding-scale insulin as monotherapy—only 38% achieve mean glucose <140 mg/dL versus 68% with scheduled basal-bolus therapy. 3
• Do not continue escalating basal insulin beyond 0.5–1.0 units/kg/day without addressing postprandial hyperglycemia—this causes over-basalization with increased hypoglycemia risk. 3
• Do not give rapid-acting insulin at bedtime as a sole correction dose—this markedly raises nocturnal hypoglycemia risk. 3
• Do not add sulfonylureas to insulin regimens—they increase hypoglycemia risk 7-fold without cardiovascular benefit. 5, 4